Skip to Main Content
E-book Library Advances in rare disease research & therapeutics

Advances in rare disease research & therapeutics

Sponsored by Intelligent Medical Objects

Rare diseases pose significant challenges for the 25-30 million individuals in the U.S. living with one of over 7,000 known rare diseases. It takes an average of seven years to diagnose a rare disease accurately, and treatment costs can easily exceed millions — if therapies exist at all. Between smaller patient populations and regulatory hurdles, research often falls short.

Layer on equitable enrollment in trials and access to care, it becomes an emergency-level problem for underserved populations in the best of situations. The community faces momentous challenges.

It is clear that those with rare diseases need more attention. This collection features a sampling of STAT’s reporting that does just that, highlighting the people, tools, improved diagnostics, and innovative technologies that are bringing light into this critical area of science.

Download this e-book to explore advocacy for increased attention to rare diseases, the need for improved diagnostics, treatment affordability, research efficiency, and equitable access to care through the latest advances in research and therapeutics for rare diseases. 

Publication date: December 2023

Print length: 105 pages

File size: 11.9 MB

File format: PDF

Language: English

Enter the information below to begin your free e-book download

About the sponsor

About the sponsor

Intelligent Medical Objects is a healthcare data enablement company that ensures clinical data integrity and quality—making patient information fit-for-purpose across the healthcare ecosystem, from hospitals to health information exchanges to payers, and beyond.

 

IMO’s vast footprint in EHRs powers our ability to capture and preserve clinical intent at the highest level of specificity. Our secure technology platform and products then help our clients to transform and extract the greatest value from their data.

 

In short, IMO is the catalyst that enables accurate documentation, precise population cohorting, optimized reimbursements, robust analytics, and better care decisions to optimize patient outcomes.